Agilent Technologies, Inc. $A Shares Sold by American Century Companies Inc.

American Century Companies Inc. reduced its position in shares of Agilent Technologies, Inc. (NYSE:A) by 55.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 283,054 shares of the medical research company’s stock after selling 358,253 shares during the quarter. American Century Companies Inc. owned about 0.10% of Agilent Technologies worth $36,330,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Flynn Zito Capital Management LLC increased its holdings in Agilent Technologies by 3.2% in the third quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock valued at $290,000 after purchasing an additional 69 shares during the period. Forum Financial Management LP grew its position in Agilent Technologies by 2.5% in the third quarter. Forum Financial Management LP now owns 2,921 shares of the medical research company’s stock worth $375,000 after acquiring an additional 70 shares in the last quarter. Wedmont Private Capital grew its position in Agilent Technologies by 2.3% during the third quarter. Wedmont Private Capital now owns 3,630 shares of the medical research company’s stock valued at $503,000 after acquiring an additional 81 shares during the last quarter. waypoint wealth counsel boosted its position in Agilent Technologies by 4.3% during the 3rd quarter. waypoint wealth counsel now owns 1,984 shares of the medical research company’s stock valued at $255,000 after buying an additional 82 shares during the period. Finally, Cibc World Market Inc. raised its holdings in Agilent Technologies by 0.3% in the 3rd quarter. Cibc World Market Inc. now owns 29,076 shares of the medical research company’s stock worth $3,732,000 after purchasing an additional 85 shares in the last quarter.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. The Goldman Sachs Group initiated coverage on shares of Agilent Technologies in a report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 target price for the company. Bank of America boosted their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a research report on Tuesday, November 25th. TD Cowen decreased their target price on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Robert W. Baird increased their target price on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research report on Tuesday, November 25th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $161.20.

Agilent Technologies Stock Performance

Shares of A opened at $115.11 on Friday. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27. The company’s 50 day simple moving average is $132.65 and its 200 day simple moving average is $135.89. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The company has a market capitalization of $32.53 billion, a price-to-earnings ratio of 25.41, a PEG ratio of 2.49 and a beta of 1.31.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same period in the previous year, the company earned $1.31 earnings per share. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be given a $0.255 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s payout ratio is 22.52%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.